Astellas (OTCPK:ALPMF) announced Thursday that Chinese regulators agreed to review a request to expand the label of Padcev, an antibody-drug conjugate it co-develops with Pfizer (NYSE:PFE), as a first...
Source LinkAstellas (OTCPK:ALPMF) announced Thursday that Chinese regulators agreed to review a request to expand the label of Padcev, an antibody-drug conjugate it co-develops with Pfizer (NYSE:PFE), as a first...
Source Link
Comments